From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio
Tumor dose (Gy)
Liver dose (Gy)
Tumor involvement (%)
p = 0.003*
p < 0.0001*
Tumor to liver ratio
p = 0.47
Administered activity
p > 0.99
Disease type
p = 0.65
p = 0.20